279. Huge venous malformation with cervical, oral and pharyngeal diffuse lesion Clinical trials / Disease details
Clinical trials : 15 / Drugs : 24 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 105
Showing 1 to 10 of 15 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ChiCTR2100053242 | 2022-06-12 | 2021-11-17 | Clinical study on the safety and efficacy of fibrin glue combined with local injection of pingyangmycin in the treatment of head and neck venous malformations Clinical study on the safety and efficacy of fibrin glue combined with local injection of pingyangmy ... | A prospective, open-label, single-arm, phase II clinical trial to evaluate the efficacy of pingyangmycin combined with fibrin glue in the treatment of head and neck venous malformations A prospective, open-label, single-arm, phase II clinical trial to evaluate the efficacy of pingyangm ... | Head and Neck Venous Malformation | Experimental group:Pingyangmycin combined with local injection of fibrin glue; | The First Affiliated Hospital of Sun Yat-Sen University | NULL | Recruiting | 1 | 70 | Both | Experimental group:20; | Phase 2 | China |
2 | NCT04861064 (ClinicalTrials.gov) | January 18, 2022 | 23/4/2021 | Weekly Sirolimus Therapy | Weekly Sirolimus Therapy for the Treatment of Venous and Lymphatic Malformations | Venous Malformation;Lymphatic Malformation | Drug: Sirolimus | Medical University of South Carolina | NULL | Recruiting | 2 Years | N/A | All | 24 | Phase 2 | United States |
3 | ChiCTR2100052762 | 2021-11-01 | 2021-11-05 | Efficacy and safety of topical sirolimus and laser in the treatment of verrucous venous malformations Efficacy and safety of topical sirolimus and laser in the treatment of verrucous venous malformation ... | Efficacy and safety of topical sirolimus and laser in the treatment of verrucous venous malformations Efficacy and safety of topical sirolimus and laser in the treatment of verrucous venous malformation ... | Verrucous Venous Malformation | group 1:topical sirolimus ;group 2:laser ; | Shanghai Ninth People's Hospital | NULL | Pending | 0 | 65 | Both | group 1:25;group 2:25; | China | |
4 | JPRN-jRCT2051200046 | 15/01/2021 | 25/08/2020 | A study for evaluation of efficacy and safety of ethanolamine oleate in patients with venous malformations A study for evaluation of efficacy and safety of ethanolamine oleate in patients with venous malform ... | Evaluation of efficacy and safety of ethanolamine oleate in sclerotherapy in patients with venous malformations: A multicenter, open-label, single-arm study - EO-1 Evaluation of efficacy and safety of ethanolamine oleate in sclerotherapy in patients with venous ma ... | Venous malformation difficult to remove | Injection of 5% ethanolamine oleate which is double diluted by contrast or normal saline for the venous malformation, within maximum dosage of 0.4 mL/kg. Same method of administration is performed for children. Maximum volume of the drug in once treatment is 30 mL after preparation. Injection of 5% ethanolamineoleatewhich is double diluted by contrast or normal saline for the venou ... | Nomura Tadashi | Nomura Tadashi;Ozaki Mine | Recruiting | Not applicable | Not applicable | Both | 44 | Phase 3 | Japan |
5 | JPRN-jRCTs061200036 | 11/12/2020 | 11/12/2020 | Prospective trial to verify the efficacy and safety of sclerotherapy with polidocanol for painful venous malformations Prospective trial to verify the efficacy and safety of sclerotherapy with polidocanol for painful ve ... | A single-center, one-arm, prospective, openlabel trial to verify the efficacy and safety of sclerotherapy with polidocanol for painful venous malformations - SCIRO-2001 A single-center, one-arm, prospective, openlabel trial to verify the efficacy and safety of scleroth ... | Painful venous malformations | Sclerotherapy with polidocanol | Uka Mayu | NULL | Recruiting | >= 12age old | Not applicable | Both | 13 | N/A | Japan |
6 | NCT04258046 (ClinicalTrials.gov) | March 31, 2020 | 16/1/2020 | Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation | Phase II Clinical Trial of MEK Inhibitor Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation (VM) Phase II Clinical Trial of MEK Inhibitor Trametinib in the Treatment of Complicated Extracranial Art ... | Venous Malformation;Arterial Disease | Drug: Trametinib tablet | Stanford University | Boston Children's Hospital | Not yet recruiting | 12 Years | 60 Years | All | 30 | Phase 2 | United States |
7 | NCT04930952 (ClinicalTrials.gov) | February 28, 2019 | 11/6/2021 | Complications of Ethanol-amine Oleate Intralesional Sclerotherapy | Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous ... | Venous Malformation | Drug: Ethanol-amine Oleate Sclerotherapy Injection | Suez Canal University | NULL | Completed | N/A | 12 Years | All | 15 | Egypt | |
8 | NCT03767660 (ClinicalTrials.gov) | July 31, 2018 | 24/11/2018 | Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformat ... | Efficacy of Rapamycin (Sirolimus) in the Treatment of Blue Rubber Bleb Nevus Syndrome, Hereditary or Sporadic Venous Malformation Efficacy of Rapamycin (Sirolimus) in the Treatment of Blue Rubber Bleb Nevus Syndrome, Hereditary or ... | Blue Rubber Bleb Nevus Syndrome;Venous Malformation | Drug: Rapamycin | Peking Union Medical College Hospital | Air Force General Hospital of the PLA;Chinese Academy of Medical Sciences | Recruiting | N/A | N/A | All | 20 | Phase 4 | China |
9 | ChiCTR-OIB-15007455 | 2015-03-18 | 2015-11-24 | Effect of sclerotherapy on venous malformation associated with localized intravascular coagulopathy: A prospective, before-after controlled study Effect of sclerotherapy on venous malformationassociated with localized intravascular coagulopathy: ... | Effect of sclerotherapy on venous malformation associated with localized intravascular coagulopathy: A prospective, before-after controlled study Effect of sclerotherapy on venous malformationassociated with localized intravascular coagulopathy: ... | venous malformation | 1:sclerotherapy with ethanol; | Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine | NULL | Recruiting | Both | 1:40; | I (Phase 1 study) | China | ||
10 | EUCTR2011-001455-37-NO (EUCTR) | 21/12/2011 | 01/06/2011 | Prospective randomized interventional study in patients with venous malformations. | Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium Sulphate (Fibrovein) in the treatment of venous malformations. Clinical neurological and neurophysiological study of a subpopulation of patients with venous malformations. Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium S ... | Venous malformation MedDRA version: 13.1;Level: LLT;Classification code 10047229;Term: Venous malformation NOS;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Venous malformation MedDRA version: 13.1;Level: LLT;Classification code 10047229;Term: Venous malfor ... | Trade Name: Bleomycin Baxter Product Name: Bleomycin Trade Name: Fibrovein 3% Product Name: Fibrovein 3% | Department of Radiology, Oslo University Hospital, Norway | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Norway |